Abstract
Methoxypromazine maleate apparently has the same sedative and tranquilizing action as chlorpromazine, but is less potent than the latter drug, particularly in cases of acute psychosis.
Clinical studies indicate that methoxypromazine maleate is suitable for the treatment of ambulatory patients with predominantly psychosomatic complaints. Studies so far indicate a minimal incidence of toxic or neurovegetative side effects.